BeStock  
Stocks › Biotechnology › STOK

Stoke Therapeutics STOK

US equityMarket cap rank #2770Biotechnology
$26.81 −$0.12 (-0.45%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.40 +2.20%
Open$26.39
Prev close$26.93
Day range$25.94 – $27.78
Volume615.8K
Market cap$1.75B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership123.0%-5.58 pts vs. prior quarter
Institutions holding237-6 vs. prior quarter
Insider trades (recent)24 buys / 26 sellsNet selling
Short interest16.54% of floatDays to cover 6.8 · as of 30 Oct 2026
Short-sale volume share29.0%5-day average of daily volume

Short-sale volume as % of daily volume

4%16%29%42%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$8.10M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$8.9MSuper+$762.0KBig−$949.7KMid+$1.6MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 39.9% of shares outstanding.

Largest holders

  • BlackRock9.71%
  • RTW Investments, LP8.60%
  • T. Rowe Price Group, Inc.7.76%
  • FMR7.65%
  • Lynx1 Capital Management LP6.17%
  • Redmile Group, LLC6.03%
  • BVF Partners L.P.5.52%
  • Wellington Management Group5.38%

By investor type

  • Mutual Fund72.57%
  • Hedge Fund33.86%
  • Public Company11.15%
  • VC/PE Fund4.16%
  • Individual/Insider3.65%
  • Government Pension Fund0.36%
  • Private Company0.35%
  • Insurance Company0.26%

Reported short interest has fallen from 20.11% to 16.54% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +470,474 9.7%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +146,480 4.2%
Victory Capital Management Inc. Mutual Fund 2026/Q3 +62,073 0.2%
SYM Financial Corporation Mutual Fund 2026/Q3 +60,071 0.1%
BVF Partners L.P. Hedge Fund 2026/Q3 +1,061,411 5.5%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +115,683 0.2%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +2,891,794 7.8%
EcoR1 Capital, LLC Hedge Fund 2026/Q3 +635,000 1.1%
State Street Global Advisors Mutual Fund 2026/Q3 +575,728 4.4%
BlackRock Mutual Fund 2026/Q3 +491,643 9.1%
Wellington Management Group Mutual Fund 2026/Q3 +423,601 5.4%
Citadel Advisors LLC Hedge Fund 2026/Q3 +366,279 0.7%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +327,454 0.8%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +276,890 4.6%
Jane Street Group, LLC Private Company 2026/Q3 +267,352 0.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
1 Nov 2026 Barry Ticho Chief Medical Officer Automatic Disposition -7,195 $26.99 11,864
1 Oct 2026 Jonathan Allan Corporate Secretary, Compliance Officer & General Counsel Automatic Disposition -627 $26.33 20,598
30 Sep 2026 Barry Ticho Chief Medical Officer Automatic Disposition -1,051 $26.16 19,059
22 Sep 2026 Alexander Cumbo Director Other Derivative Acquisition +39,674 $26.11 39,674
31 Aug 2026 Barry Ticho Chief Medical Officer Automatic Disposition -5,545 $31.06 20,110
17 Aug 2026 Edward Kaye Former Advisor & Director Derivative Exercise and Sale -12,567 $32.47 124,557
17 Aug 2026 Barry Ticho Chief Medical Officer Derivative Exercise and Sale -4,767 $32.47 25,655
17 Aug 2026 Jonathan Allan Corporate Secretary, Compliance Officer & General Counsel Derivative Exercise and Sale -2,861 $32.47 21,225
13 Aug 2026 Edward Kaye Former Advisor & Director Derivative Exercise and Retained +13,683 – 124,557
13 Aug 2026 Barry Ticho Chief Medical Officer Derivative Exercise and Retained +5,233 – 25,655
13 Aug 2026 Jonathan Allan Corporate Secretary, Compliance Officer & General Counsel Derivative Exercise and Retained +3,139 – 21,225
2 Aug 2026 Barry Ticho Chief Medical Officer Automatic Disposition -7,176 $29.45 20,422
15 Jul 2026 Seth Harrison Independent Director Other Derivative Acquisition +151,595 $40.37 17,786
15 Jul 2026 Seth Harrison Independent Director Other Derivative Disposition -151,595 $40.37 –
14 Jul 2026 Thomas McCauley Chief Scientific Officer Other Derivative Acquisition +225,000 $29.91 225,000
30 Jun 2026 Barry Ticho Chief Medical Officer Automatic Disposition -7,228 $33.27 27,598
15 Jun 2026 Jonathan Allan Corporate Secretary, Compliance Officer & General Counsel Automatic Disposition -1,457 $29.95 18,086
2 Jun 2026 Seth Harrison Independent Director Other Derivative Acquisition +17,786 $29.46 17,786
2 Jun 2026 Arthur Levin Independent Director Other Derivative Acquisition +17,786 $29.46 17,786
2 Jun 2026 Julie Smith Independent Director Other Derivative Acquisition +17,786 $29.46 17,786

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 10,722,415 16.5% 6.8
15 Oct 2026 10,256,830 15.9% 12.3
30 Sep 2026 11,505,410 17.8% 10.2
15 Sep 2026 11,150,236 17.3% 17.3
31 Aug 2026 11,203,427 17.4% 11.9
14 Aug 2026 12,978,102 20.1% 12.7

Discussion

No comments yet — be the first to weigh in on STOK.

Sign in to join the discussion.

Scroll to Top